Considerations in Applying Benefit-Cost Analysis to Preventive Interventions for Children, Youth, and Families:

Considerations in Applying Benefit-Cost Analysis to Preventive Interventions for Children, Youth, and Families:

Title: Considerations in Applying Benefit-Cost Analysis to Preventive Interventions for Children, Youth, and Families:
Author: Steve Olson, Board on Children, Youth, and Families, Institute of Medicine & National Research Council
Release: 2014-03-31
Kind: ebook
Genre: Medical, Books, Professional & Technical
Size: 899290
Benefit-cost analyses hold great promise for influencing policies related to children, youth, and families. By comparing the costs of preventive interventions with the long-term benefits of those interventions, benefit-cost analysis provides a tool for determining what kinds of investments have the greatest potential to reduce the physical, mental, and behavioral health problems of young people. More generally, the growth of benefit-cost analysis as a field of research and practice represents an exciting and promising trend in the development and implementation of public policies.
The utility of benefit-cost analyses has been limited by a lack of uniformity in the methods and assumptions underlying these studies. For years, those who perform and those who use benefit-cost analyses have argued that the development and use of theoretical, technical, and reporting standards for benefit-cost analyses would enhance the validity of results, increase comparability across studies, and accelerate the progress of the field.
Considerations in Applying Benefit-Cost Analysis to Preventive Interventions for Children, Youth, and Families is the summary of a workshop convened by the Board on Children, Youth, and Families of the Institute of Medicine and the National Research Council in November 2013 as the first phase of a possible two-part effort directed toward guiding future benefit-cost studies and enhancing the relevance of benefit-cost analysis to governments and other organizations wanting to make sound prevention decisions. The workshop brought together leading practitioners in the field, researchers who study the methodological and analytic dimensions of benefit-cost analysis, and representatives of organizations that use the results of benefit-cost analyses to shape and implement public policies. This report discusses a wide range of issues about benefit-cost analysis, including the level of research rigor that should be met before results from an evaluation are used to estimate or predict outcomes in a cost-benefit analysis; best practices and methodologies for costing prevention interventions; prevention outcomes that currently lend themselves to monetization; processes and methodologies that should be used when linking prevention outcomes to avoided costs or increased revenues; and best methods for handling risk and uncertainty in estimates.

More Books from Steve Olson, Board on Children, Youth, and Families, Institute of Medicine & National Research Council

Greg Graffin & Steve Olson
Steve Olson, Board on Children, Youth, and Families, Institute of Medicine & National Research Council
Steve Olson, Board on Children, Youth, and Families, Institute of Medicine & National Research Council
Steve Olson, Committee on Science, Engineering, and Public Policy, Policy and Global Affairs, National Academy of Sciences, National Academy of Engineering & Institute of Medicine
Steve Olson, Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy & Institute of Medicine
Steve Olson, National Academy of Engineering & National Academies
Tracy A. Lustig, Steve Olson, Forum on Aging, Disability, and Independence, Board on Health Sciences Policy, Division of Behavioral and Social Sciences and Education, Institute of Medicine & National Research Council
Steve Olson, Forum on Drug Discovery, Development, and Translation, Forum on Neuroscience and Nervous System Disorders, National Cancer Policy Forum, Roundtable on Translating Genomic-Based Research on Health, Board on Health Sciences Policy, Board on Health Care Services & Institute of Medicine
Proctor Reid, Steve Olson, National Academy of Engineering, National Park Service & John A. Volpe National Transportation Systems Center
Steve Olson, Board on Global Health & Institute of Medicine
Steve Olson, Forum on Drug Discovery, Development, and Translation & Institute of Medicine
Steve Olson, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy & Institute of Medicine
Steve Olson, Adam Berger, Roundtable on Translating Genomic-Based Research on Health & Institute of Medicine
Steve Olson, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy & Institute of Medicine
Steve Olson, Food and Nutrition Board & Institute of Medicine
Steve Olson, Roundtable on Obesity Solutions, Food and Nutrition Board & Institute of Medicine
Steve Olson, Committee on Increasing National Resilience to Hazards and Disasters, Committee on Science, Engineering, and Public Policy, Disasters Roundtable, Division on Earth and Life Studies, Policy and Global Affairs & National Research Council
Steve Olson & Institute of Medicine
Steve Olson & National Academy of Engineering
Steve Olson, Planning Committee on Thinking Evolutionarily: Making Biology Education Make Sense, Board on Life Sciences, Division on Earth and Life Studies & National Research Council
Steve Olson, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine & Russian Academy of Medical Sciences
Steve Olson, Roundtable on Translating Genomic-Based Research for Health & Institute of Medicine
Andrew Robertson, Steve Olson, National Academy of Engineering & United States Institute of Peace